Cipla launches knowledge sharing platform ‘Ciplamed 2.0’
CiplaMed 2.0 leverages advanced analytics and automation
CiplaMed 2.0 leverages advanced analytics and automation
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
The survey findings for Delhi-NCR revealed that speech sound disorders exhibit higher prevalence rates in the 6-12 years age group
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
ELREXFIO’s label contains a boxed warning for cytokine release syndrome and neurologic toxicity
Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
This is the 166th ANDA out of Eugia Pharma Speciality Group facilities
Continuous learning is not just an option but a responsibility that every healthcare professional must shoulder
Aurobindo Pharma has reported total income of Rs. 6966.85 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated